home Latest News Top Ranked Growth Stocks to Buy for April 16th – Zacks.com

Top Ranked Growth Stocks to Buy for April 16th – Zacks.com

This post was originally published on this site

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 16th:

ICF International, Inc. (ICFI Free Report) : This management services provider, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.5% over the last 60 days.

ICF International, Inc. Price and Consensus

ICF has a PEG ratio of 1.73, compared with 2.00 for the industry. The company possesses a Growth Score of A.

ICF International, Inc. PEG Ratio (TTM)

The Marcus Corporation (MCS Free Report) : This movie theatres operator, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.

Marcus Corporation (The) Price and Consensus

Marcus has a PEG ratio of 1.14, compared with 2.61 for the industry. The company possesses a Growth Score of A.

Marcus Corporation (The) PEG Ratio (TTM)

EMCOR Group, Inc. (EME Free Report) : This construction services provider, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 11.2% over the last 60 days.

EMCOR Group, Inc. Price and Consensus

EMCOR has a PEG ratio of 1.17, compared with 1.23 for the industry. The company possesses a Growth Score of A.

EMCOR Group, Inc. PEG Ratio (TTM)

Urban Outfitters, Inc. (URBN Free Report) : This lifestyle products and services company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 18.2% over the last 60 days.

Urban Outfitters, Inc. Price and Consensus

Urban Outfitters has a PEG ratio 1.43, compared with 1.60 for the industry. The company possesses a Growth Score of A.

Urban Outfitters, Inc. PEG Ratio (TTM)

See the full list of top ranked stocks here                                    

Learn more about the Growth score and how it is calculated here.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>